ABSTRACT

Coronavirus disease 2019 (COVID-19) infections may be associated with a wide range of bacterial and fungal co-infections. There has been a rapid rise in the number of COVID-19- associated rhino-orbital mucormycosis cases to an extent that it has been considered an epidemic among the COVID-19 patients in India. Here, we report a case of rhino-orbital- cerebral mucormycosis (ROCM) in a patient recovered from COVID-19 infection with uncontrolled Diabetes mellitus (DM). A 53 year old diabetic patient was admitted with a diagnosis of covid-19 based on positive RT-PCR and CT of lungs. He was treated with corticosteroids. Then the patients was readmitted to hospital due to right sided facial pain, swelling and vision loss of right eye after several days of discharge. A right endoscopic pansinus disease clearance was done and specimens sent for biopsy. The nasal biopsy showed mucormycosis. The patient was treated with IV antifungals and antibiotics. Our reports highlights that all physicians including ophthalmologists should, therefore, be mindful of the probability of development of fungal infections such as mucormycosis in patients with COVID-19 illness, especially in those with comorbidities and on immunosuppressive agents in the coming future. Keywords: COVID-19, Rhino-orbital mucormycosis, diabetes, corticosteroids, antifungals
Publication date: 01/09/2023

https://ijbpas.com/pdf/2023/September/MS_IJBPAS_2023_7289.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2023/12.9.7289